Novartis&#39; Urinary Incontinence Drug Approved
165412
Enablex, also known as darifenacin, was approved by the Food and Drug Administration. Novartis (nyse: NVS - news - people ) had purchased the drug from Pfizer (nyse: PFE - news - people ) for $225 million
325918
At least that&#39;s what NABI Biopharmaceuticals (Nasdaq: NABI) suggests based on the results of a small phase 2 trial with the drug NicVAX that was released yesterday.
32747
Swiss pharmaceutical maker Novartis AG said Tuesday it has received U.S. approval for the hypertension drug Tekturna &#151; a potential blockbuster that has shown the ability to lower blood pressure more effectively than common treatments.
369605
Government's drugs watchdog approves health service provision of varenicline.
156827
The drugmaker Novartis AG said Monday that the European Commission had approved its Exelon skin patch to treat Alzheimer's disease.
678678
Austrian doctors reported yesterday that they&#39;ve successfully treated women suffering from urinary stress incontinence with their own muscle-derived stem cells.
39535
Sanofi-Aventis said on Friday that U.S. regulators had approved wider use for its colon cancer drug Eloxatin, lifting shares in the world's third-largest pharmaceuticals group.
667565
Novartis AG      won U.S. approval to  promote the drug Femara for women who have finished standard  therapy for early-stage breast cancer and run out of options,  the company said on Friday.
550582
Swiss pharmaceuticals group Novartis  has concluded a $500 million, 7-year global infrastructure contract with British telecoms group BT , a Novartis spokesman said on Sunday.
556452
Eli Lilly and Co. LLY.N said on  Tuesday that U.S. regulators have approved its new  antidepressant Cymbalta as a treatment for pain associated with  nerve damage in diabetics, making it the first drug to be  approved for the disorder.
742333
Sepracor Inc., a specialty  pharmaceutical company, said on Wednesday it received a  long-awaited approval to market its Lunesta treatment for  insomnia, giving it a foothold in an estimated $2 billion  market in the United States.
339598
Novartis AG      won U.S. approval to promote the drug Femara for women who have finished standard therapy for early-stage breast cancer and run out of options, the company said on Friday.
725058
Austrian researchers say they have successfully used their female patients&#39; own stem cells to treat urinary incontinence. The therapy is a potentially long-lasting one, with patients remaining continent one year after treatment, HealthDay reported.
214401
The Pittsburg-based generic drugmaker said the Food and Drug Administration has approved its metoprolol tartrate and hydrochlorothiazide tablets, which will compete with the Loppressor HCT tablets made by the Switzerland-based Novartis.
637397
AstraZeneca Plc has won U.S. approval to market its Nexium ulcer pill as a treatment that reduces the risk of ulcers developing in patients on non-steroidal anti-inflammatory drugs, it said on Monday.
10160
Novartis Pharmaceuticals Corp., the U.S. unit of Swiss drugmaker Novartis AG, said Thursday that at least three out of four patients given an experimental multiple sclerosis treatment were free of relapses for more than two years.
309289
Roche Holding, the drug company, has received European Union approval for its colon cancer treatment Avastin.